Hematopoietic stem cell trans- plantation targeted diseases such as hematological diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1)Patients who were first transplanted from January 2010.(Patients past of autologous transplantation history in is possible registration, autologous transplantation does not count.) (2)Patients who survived for 150 days and above after last transplantation without relapse at study. (3)Patients who aged 20 or above at transplantation. (4)Patients who were accounted for this study in detail and signed a written informed consents.
Exclusion criteria
Exclusion criteria: (1) Patients who were unable to read, understand, or reply to FACT-BMT, SF-36, and the questionnaire about life and social environment. (2) Patients who are disqualified by their attending physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| (1)Incidence and risk factors of organ dysfunction and late effects in long-term survivors after transplantation. (2)Changes of QOL in long-term survivors after transplantation. (3) Influence of organ dysfunction and late effects on QOL and life in patients after transplantation. | — |
Countries
Japan
Contacts
Nagoya University Hospital Department of Hematology